NRX Pharmaceuticals, Inc.: Form 8-K/A, filed Nov 21, 2025
Filed with the SEC on Nov 21, 2025 and accepted by EDGAR at Nov 21, 2025, 16:32 ET.
Items reported
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001437749-25-036005. Last ingested by Listed: Nov 2, 2026, 08:07 ET. Listed shows no prices and gives no investment advice.